Latest News about BIIB
Recent news which mentions BIIB
10 Worst Performing Large-Caps Last 12 Months
May 22, 2025
From TalkMarkets
10 Worst Performing Large-Caps Last 12 Months
May 15, 2025
From TalkMarkets
From Benzinga
10 Worst Performing Large-Caps Last 12 Months
May 08, 2025
From TalkMarkets
4 Stocks to Buy for a Potential “Summer Panic”
May 04, 2025
From InvestorPlace
Biogen Beats Q1 Earnings Expectations As Two Newcomer Drug Sales Spike, Avoids Tariff Impact
May 01, 2025
From Benzinga
10 Worst Performing Large-Caps Last 12 Months
May 01, 2025
From TalkMarkets
Earnings Scheduled For May 1, 2025
May 01, 2025
From Benzinga
From Benzinga
Europe Approves Eisai-Biogen's Alzheimer's Drug 'Under Strict Conditions' After Initial Negative Opinion
April 16, 2025
From Benzinga
Vertex, Alnylam Best Positioned As Biopharma Braces For Tariff Impact, Goldman Sachs Flags Regeneron, Biogen Risks
April 04, 2025
From Benzinga
European Drug Regulator Gives Thumbs Down To Eli Lilly's Alzheimer's Drug, Analyst Says It Is Incremental Win For Biogen
March 28, 2025
From Benzinga
From Motley Fool
From Benzinga
Novartis New Data From Single-Dose Gene Therapy Shows Meaningful Efficacy, Safety In Patients With Spinal Muscular Atrophy
March 19, 2025
From Benzinga
From Benzinga
NHS England's Transition From Biogen's Drug To Sandoz's Biosimilar Sparks Alarm As Multiple Sclerosis Patients Report Severe Effects
February 24, 2025
From Benzinga
Biogen Strengthens Pipeline With Stoke Therapeutic's Dravet Syndrome Candidate Via Multi-Million Dollar Deal
February 18, 2025
From Benzinga
Leqembi And Skyclarys Expected To Drive Biogen's Future Growth: Analysts
February 13, 2025
From Benzinga
Biogen Analysts Lower Their Forecasts After Q4 Results
February 13, 2025
From Benzinga
Forecasting The Future: 10 Analyst Projections For Biogen
February 13, 2025
Tickers
BIIB
From Benzinga
From Benzinga
Stocks Trim Losses After Hot Inflation, Bonds Remain Pressured, Tesla Rebounds: What's Driving Markets Wednesday?
February 12, 2025
From Benzinga
Biogen Q4 Earnings: Revenue And EPS Beat, Warns Lower 2025 Revenue, Inks R&D Funding Pact With Royalty Pharma
February 12, 2025
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.